Being the most common mutation, DNMT3A R882H mutation can not only lower methylation enzymatic activity [38, 39] but can also co-act with other proteins to influence immune activity, cell apoptosis, proliferation, and DNA damage repair to regulate AML [40–42]. This evidence concerns the gene DNMT3A and acute myeloid leukemia.